Dr. Christopher K. Cheng, MD

Dr. Cheng practices at Pls Surgery Center LP in Arcadia, California.

Dr. Cheng's NPI, 1700175312, was assigned on April 4, 2011. Dr. Cheng graduated from SUNY Downstate Health Sciences University in 2011. Dr. Cheng holds California license A133131.

Dr. Cheng's primary practice is Pls Surgery Center LP, at 624 W Duarte Rd, Arcadia, CA 91007 in Los Angeles County. The practice phone is (626) 447-2886.

Dr. Cheng's primary practice is Pls Surgery Center LP in Arcadia, California. Dr. Cheng is also affiliated with OSF Saint Francis Medical Center. The medical group on file is IntraNerve Neuroscience. Dmand AI also links Dr. Cheng to 5 more hospitals, 12 medical groups, 4 group practices and clinics and 2 physician offices, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheng practices, 12 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Cheng's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Cheng is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Cheng's licenses on file in 15 states: California, South Dakota, Colorado, New Jersey, Ohio, South Carolina, Florida, Hawaii, Illinois, Maine, Missouri, Mississippi, Pennsylvania, Tennessee and Washington.

Dmand AI lists carpal tunnel syndrome, epilepsy, fibromyalgia and chronic pain, hereditary polyneuropathy, hypersomnia, lower back pain, migraine and chronic headache and nerve damage among the conditions Dr. Cheng treats.

CMS data shows 1,050 Medicare services from Dr. Cheng across 12 procedure codes in 2024, for 428 Medicare patients. Medicare paid $97,973 for them.

CMS counts 428 Medicare patients who saw Dr. Cheng in 2024. The largest group is 65 to 74, with 161 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheng's median patient age at 63, with 50% women.

In 2024, Dr. Cheng wrote 618 Medicare Part D claims for 116 patients. 81% of them were for generic drugs. CMS names the drug for 357 of them, across 17 drugs with 11 or more claims each, at $304,992 in total drug cost. In 2023, CMS named 911 claims across 35 drugs.

Dr. Cheng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cheng as offering telehealth.

Dmand AI links 33 papers to Dr. Cheng, published from 2011 to 2024. 2018 was the busiest year, with 6. The most frequent topics are Nanoparticles, MicroRNAs and Cell Line, Tumor. Dr. Cheng has published most often in Proc Natl Acad Sci U S A. Dr. Cheng's most frequent co-authors are Seema Agarwal, MD, Abdurrahman Al-Awady and Sandy Chang, MD, PhD.

CMS Open Payments shows 142 general payments to Dr. Cheng from 34 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 83% of the total. W. L. Gore & Associates, Inc. paid the most, $14,100.

Dr. Cheng graduated from SUNY Downstate Health Sciences University in 2011.

Dr. Cheng is in network with 21 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.